Cookie Policy

This site uses cookies to store information on your computer.

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

 

 

First patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientshttp://www.terumo-europe.com/en-emea/news/first-patient-enrolled-in-major-new-study-investigating-abbreviated-dapt-post-stent-in-high-bleeding-risk-patientsFirst patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientsEmmen, The Netherlands03/04/2017 22:00:00
Terumo announces first commercial clinical case using QuiremSpheres®http://www.terumo-europe.com/en-emea/news/terumo-announces-first-commercial-clinical-case-using-quiremspheres®Terumo announces first commercial clinical case using QuiremSpheres®Leuven, Belgium27/03/2017 22:00:00
Terumo and Toxikon Europe NV announce a strategic partnershiphttp://www.terumo-europe.com/en-emea/news/terumo-and-toxikon-europe-nv-announce-a-strategic-partnershipTerumo and Toxikon Europe NV announce a strategic partnershipLeuven, Belgium05/03/2017 23:00:00

 

 

GEST 2017http://www.terumo-europe.com/en-emea/Events/GEST 2017.aspxGEST 2017Italy30/05/2017 22:00:0003/06/2017 12:13:00Florencehttp://www.gest2017.eu/, http://www.gest2017.eu/
TOPIC 2017http://www.terumo-europe.com/en-emea/Events/TOPIC 2017.aspxTOPIC 2017Japan19/07/2017 22:00:0022/07/2017 12:24:00Tokyohttp://www.topic.gr.jp/english/, http://www.topic.gr.jp/english/